Authors:
HABERKORN U
KREMS B
GERLACH L
MORR I
BACHERT P
STRAUSS LG
DIMITRAKOPOULOUSTRAUSS A
WIESSLER M
VANKAICK G
Citation: U. Haberkorn et al., ASSESSMENT OF GLUCOSYLIFOSFAMIDE BIODISTRIBUTION IN RATS WITH PROSTATE ADENOCARCINOMA, The Journal of nuclear medicine, 37(5), 1996, pp. 1183-1183
Authors:
DIMITRAKOPOULOUSSTRAUSS A
GUTZLER F
STRAUSS LG
IRNGARTINGER G
OBERDORFER F
DOLL J
STREMMEL W
VANKAICK G
Citation: A. Dimitrakopoulousstrauss et al., POSITRON EMISSION TOMOGRAPHY STUDIES WITH C-11 ETHANOL IN INTRATUMORAL THERAPY FOR HEPATIC CELL-CARCINOMA, Radiologe, 36(9), 1996, pp. 744-749
Authors:
GUTZLER F
DIMITRAKOPOULOUSTRAUSS A
OBERDORFER F
MOEHLER M
STRAUSS LG
STREMMEL W
Citation: F. Gutzler et al., EVALUATION OF PERCUTANEOUS ETHANOL INJECTION IN HEPATOCELLULAR-CARCINOMA BY C-11 ETHANOL AND F-18 DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY, Gastroenterology, 110(4), 1996, pp. 524-524
Authors:
REISSER C
HABERKORN U
DIMITRAKOPOULOUSTRAUSS A
SEIFERT E
STRAUSS LG
Citation: C. Reisser et al., CHEMOTHERAPEUTIC MANAGEMENT OF HEAD AND NECK MALIGNANCIES WITH POSITRON EMISSION TOMOGRAPHY, Archives of otolaryngology, head & neck surgery, 121(3), 1995, pp. 272-276
Authors:
DIMITRAKOPOULOUSTRAUSS A
STRAUSS LG
GOLDSCHMIDT H
LORENZ WJ
MAIERBORST W
VANKAICK G
Citation: A. Dimitrakopouloustrauss et al., EVALUATION OF TUMOR METABOLISM AND MULTIDRUG-RESISTANCE IN PATIENTS WITH TREATED MALIGNANT-LYMPHOMAS, European journal of nuclear medicine, 22(5), 1995, pp. 434-442
Authors:
HUNDESHAGEN H
BIERSACK HJ
BULL U
FELIX R
GUNNEWIG BJ
HEISS WD
HOR G
JORDAN K
KNAPP WH
MULLERGARTNER HW
REINERS C
RESKE S
SCHICHA H
SCHOBER O
SCHWAIGER M
STOCKLIN G
STRAUSS LG
Citation: H. Hundeshagen et al., POSITRON-EMISSION-TOMOGRAPHY - CLINICAL R ESEARCH, DIAGNOSTIC-VALUE, FUTURE-DEVELOPMENT - SURVEY 1994, Nuklearmedizin, 33(2), 1994, pp. 145-153
Authors:
HABERKORN U
OBERDORFER F
KLENNER T
STRAUSS LG
STOHR M
WALLICH R
ALTMANN A
VANKAICK G
Citation: U. Haberkorn et al., METABOLIC AND TRANSCRIPTIONAL CHANGES IN OSTEOSARCOMA CELLS TREATED WITH CHEMOTHERAPEUTIC DRUGS, Nuclear medicine and biology, 21(6), 1994, pp. 835-845
Authors:
REISSER C
TASMAN AJ
HABERKORN U
STRAUSS LG
Citation: C. Reisser et al., DIFFERENTIAL-DIAGNOSIS OF SUSPICIOUS MASS IN THE NECK USING POSITRON-EMISSION TOMOGRAPHY, Laryngo-, Rhino-, Otologie, 73(10), 1994, pp. 523-526
Authors:
REISSER C
TASMAN AJ
HABERKORN U
STRAUSS LG
Citation: C. Reisser et al., DIFFERENTIAL-DIAGNOSIS OF SUSPICIOUS MASS IN THE NECK USING POSITRON-EMISSION TOMOGRAPHY, Laryngo-, Rhino-, Otologie, 73(10), 1994, pp. 523-526
Authors:
STRAUSS LG
DIMITRAKOPOULOUSTRAUSS A
VANKAICK G
Citation: Lg. Strauss et al., PET STUDIES WITH F-18 DEOXYGLUCOSE (FDG) IN PATIENTS WITH METASTATIC MELANOMA PRIOR AND AFTER THERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000038-160000038
Authors:
DIMITRAKOPOULOUSTRAUSS A
STRAUSS LG
OBERDORFER F
LORENZ WJ
VANKAICK G
Citation: A. Dimitrakopouloustrauss et al., PET STUDIES WITH F-18 URACIL IN PATIENTS WITH LIVER METASTASES RECEIVING INTRAARTERIAL CHEMOTHERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000038-160000038
Authors:
HABERKORN U
ZIEGLER SI
OBERDORFER F
STRAUSS LG
DOLL J
VANKAICK G
Citation: U. Haberkorn et al., RELATION OF FDG UPTAKE TO PROLIFERATION AND THE EXPRESSION OF GLYCOLYSIS-ASSOCIATED GENES IN ANIMAL TUMOR-MODELS, The Journal of nuclear medicine, 35(5), 1994, pp. 160000220-160000220
Authors:
DIMITRAKOPOULOUSTRAUSS A
STRAUSS LG
GOLDSCHMIDT H
LORENZ WJ
VANKAICK G
Citation: A. Dimitrakopouloustrauss et al., PET WITH FDG AND SPECT WITH TC-99M-SESTAMIBI FOR THERAPY MANAGEMENT IN PATIENTS WITH TREATED MALIGNANT-LYMPHOMAS, The Journal of nuclear medicine, 35(5), 1994, pp. 160000231-160000231
Authors:
DIMITRAKOPOULOUSTRAUSS A
STRAUSS LG
VANKAICK G
Citation: A. Dimitrakopouloustrauss et al., PERFUSION PATTERNS OF LIVER METASTASES USING INTRAVENOUS, INTRAARTERIAL AND INTRAPORTAL INJECTED O-15 LABELED WATER, The Journal of nuclear medicine, 35(5), 1994, pp. 160000236-160000236
Authors:
GOLDSCHMIDT H
HEGENBART U
DIMITRAKOPOULOUSTRAUSS A
HAAS R
STRAUSS LG
HUNSTEIN W
Citation: H. Goldschmidt et al., SEQUENTIAL POSITRON-EMISSION TOMOGRAPHY IN TREATED PATIENTS WITH MALIGNANT-LYMPHOMA, Blood, 84(10), 1994, pp. 10000158-10000158
Authors:
HOHENBERGER P
STRAUSS LG
LEHNER B
FROHMULLER S
DIMITRAKOPOULOU A
SCHLAG P
Citation: P. Hohenberger et al., PERFUSION OF COLORECTAL LIVER METASTASES AND UPTAKE OF FLUOROURACIL ASSESSED BY (H2O)-O-15 AND [F-18] URACIL POSITRON EMISSION TOMOGRAPHY (PET), European journal of cancer, 29A(12), 1993, pp. 1682-1686
Citation: C. Reisser et al., THE RELEVANCE OF POSITRON EMISSION TOMOGRAPHY FOR THE DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS, Journal of otolaryngology, 22(4), 1993, pp. 231-238
Authors:
GANN H
RIEMANN D
HOHAGEN F
STRAUSS LG
DRESSING H
MULLER WE
BERGER M
Citation: H. Gann et al., 48-HOUR RAPID-CYCLING - RESULTS OF PSYCHOPATHOMETRIC, POLYSOMNOGRAPHIC, PET IMAGING AND NEUROENDOCRINE LONGITUDINAL INVESTIGATIONS IN A SINGLE-CASE, Journal of affective disorders, 28(2), 1993, pp. 133-140
Authors:
DIMITRAKOPOULOU A
STRAUSS LG
CLORIUS JH
OSTERTAG H
SCHLAG P
HEIM M
OBERDORFER F
HELUS F
HABERKORN U
VANKAICK G
Citation: A. Dimitrakopoulou et al., STUDIES WITH POSITRON EMISSION TOMOGRAPHY AFTER SYSTEMIC ADMINISTRATION OF FLUORINE-18-URACIL IN PATIENTS WITH LIVER METASTASES FROM COLORECTAL-CARCINOMA, The Journal of nuclear medicine, 34(7), 1993, pp. 1075-1081
Authors:
DIMITRAKOPOULOU A
STRAUSS LG
HABERKORN U
HOHENBERGER P
DOLL J
WOLBER G
HELUS F
VANKAICK G
Citation: A. Dimitrakopoulou et al., PET USED TO ESTIMATE FLUOROURACIL (FU) THERAPY OUTCOME IN PATIENTS WITH LIVER METASTASES, The Journal of nuclear medicine, 34(5), 1993, pp. 218-218
Authors:
HABERKORN U
STRAUSS LG
OBERDORFER F
STOHR M
KEPPLER BK
KLENNER T
ALTMANN A
WALLICH R
DIMITRAKOPOULOU A
VANKAICK G
Citation: U. Haberkorn et al., CHANGES OF GLUCOSE-METABOLISM AND CELL-PROLIFERATION IN TREATED OSTEOSARCOMA CELLS, The Journal of nuclear medicine, 34(5), 1993, pp. 220-221
Authors:
DIMITRAKOPOULOU A
STRAUSS LG
GOLDSCHMIDT H
HABERKORN U
OSTERTAG H
OBERDORFER F
VANKAICK G
Citation: A. Dimitrakopoulou et al., POSITRON EMISSION TOMOGRAPHY (PET) FOR THERAPY MANAGEMENT IN TREATED MALIGNANT-LYMPHOMAS, The Journal of nuclear medicine, 34(5), 1993, pp. 220-220
Authors:
GOLDSCHMIDT H
SCHMITT M
DIMITTRAKOPOULOU A
HAAS R
STRAUSS LG
HUNSTEIN W
Citation: H. Goldschmidt et al., POSITRON EMISSION TOMOGRAPHY (PET) - A NEW METHOD FOR EVALUATION OF MEDIASTINAL RESIDUAL MASSES AFTER TREATMENT OF LYMPHOMA, Blood, 82(10), 1993, pp. 10000565-10000565
Authors:
SEIFERT E
SCHADEL A
HABERKORN U
STRAUSS LG
Citation: E. Seifert et al., USE OF POSITRON EMISSION TOMOGRAPHY TO EVALUATE THE EFFECTIVENESS OF CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER, HNO. Hals-, Nasen-, Ohrenarzte, 40(3), 1992, pp. 90-93